Literature DB >> 24754096

Breast conserving surgery using volume replacement with oxidized regenerated cellulose: a cosmetic outcome analysis.

Satoru Tanaka, Nayuko Sato, Hiroya Fujioka, Yuko Takahashi, Kosei Kimura, Mitsuhiko Iwamoto, Kazuhisa Uchiyama.   

Abstract

We evaluated the cosmetic outcome of volume replacement with oxidized regenerated cellulose (ORC) after breast-conserving surgery (BCS) and also examined factors that may have influenced the results. Ninety-four patients who underwent BCS with ORC replacement between January 2010 and August 2012 participated in this study. The cosmetic outcomes of these patients were evaluated using scores based on the criteria of the Japan Breast Cancer Society. We evaluated cosmetic scores with regards to several clinical factors and the occurrence of complications after this procedure. The mean score of the cosmetic outcome of all patients was 9.5 points of 12 points. Thirty-seven patients were categorized as “Excellent,” 34 were “Good,” 22 were “Fair,” and 1 was “Poor.” Patient age, body mass index, weight of the specimen, and ORC amount were not significantly different between patients with favorable cosmetic scores and those without. However, the weight of the removed specimen was slightly higher in patients with an unfavorable cosmetic score. Although acute dermatitis and eczema was observed in 15% and 3% of patients, all of them were improved with conservative treatment. Cosmetic scores were significantly higher in patients without complications than in patients with complications. In conclusion, ORC replacement after BCS is a simple and reliable procedure. The selection of indication and prevention of complications are important for obtaining a better cosmetic outcome. This is the first report to cosmetically evaluate a relatively large number of patients that have undergone ORC replacement after BCS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24754096     DOI: 10.1111/tbj.12229

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  7 in total

1.  Magnetic resonance imaging appearance of oxidized regenerated cellulose in breast cancer surgery.

Authors:  Michela Giuliani; Rossella Rella; Rita Fubelli; Federica Patrolecco; Silvia Eleonora Di Giovanni; Chiara Buccheri; Federico Padovano; Paolo Belli; Maurizio Romani; Pierluigi Rinaldi; Enida Bufi; Gianluca Franceschini; Lorenzo Bonomo
Journal:  Radiol Med       Date:  2016-06-04       Impact factor: 3.469

Review 2.  New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient.

Authors:  G Franceschini; A Martin Sanchez; A Di Leone; S Magno; F Moschella; C Accetta; R Masetti
Journal:  G Chir       Date:  2015 Jul-Aug

3.  The efficacy of oxidized regenerated cellulose (SurgiGuard®) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients.

Authors:  Kug Hyun Nam; Joon-Hyop Lee; Yoo Seung Chung; Yong Soon Chun; Heung Kyu Park; Yun Yeong Kim
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

4.  Observed outcomes on the use of oxidized and regenerated cellulose polymer for breast conserving surgery - A case series.

Authors:  Pier Carlo Rassu
Journal:  Ann Med Surg (Lond)       Date:  2015-12-22

5.  Comparative Evaluation of Biological Performance, Biosecurity, and Availability of Cellulose-Based Absorbable Hemostats.

Authors:  Yadong Wu; Fang Wang; Yudong Huang
Journal:  Clin Appl Thromb Hemost       Date:  2018-01-24       Impact factor: 2.389

6.  Clinical observation of the regeneration process of defects after breast cancer resection.

Authors:  Jun-Jie Li; Ye Yang; Qi Wan; Hui Li; Qi-Ming Long; Pu-Rong Zhang
Journal:  BMC Womens Health       Date:  2021-03-06       Impact factor: 2.809

7.  Breast conserving surgery using oxidized regenerated cellulose as filling biomaterial: recommendations to improve clinical outcomes.

Authors:  Gianluca Franceschini
Journal:  BMC Womens Health       Date:  2021-08-04       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.